You are here
The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.
Investigation of a sorbent-based potassium adsorber for the treatment of hyperkalemia induced by traumatic injury and acute kidney injury in austere medicineSBC: CytoSorbents Medical Inc. Topic: DHP16010
Hyperkalemia will clearly continue to be a concern in the treatment of combat casualties. The risk of death from hyperkalemia-induced cardiac arrhythmias is significant in the absence of renal replacement therapy (RRT). Rapid evacuation out of Iraq and Afghanistan ensured that most hyperkalemia occurred further up the evacuation chain, thereby limiting the need for non-RRT hyperkalemia treatment o ...SBIR Phase II 2017 Department of DefenseDefense Health Agency
Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for TransfusionSBC: CytoSorbents Medical Inc. Topic: DHP15B001
Plasma from AB donors is considered universal as it can be transfused regardless of recipient blood type and is frequently used to rapidly resuscitate massively bleeding hospital trauma patients and warfighters with combat casualties. However supplies can be rapidly depleted as AB donors make up only 4% of the population. Therefore robust a technology to cost-effectively generate universal plasma ...STTR Phase II 2017 Department of DefenseDefense Health Agency
The Characterization and Mitigation of Single Event Effects in Ultra-Deep Submicron (< 90nm) MicroelectronicsSBC: Orora Design Technologies, Inc. Topic: DTRA07005
Orora Design Technologies proposes to develop electronic design automation (EDA) tools employing minimally invasive circuit design-based methods to mitigate single event effects (SEEs) for next generation Ultra-DSM CMOS (SBIR Phase II 2008 Department of DefenseDefense Threat Reduction Agency